Lysine 419 targets human glucocorticoid receptor for proteasomal degradation.
about
Discovery of Compound A--a selective activator of the glucocorticoid receptor with anti-inflammatory and anti-cancer activityDexamethasone enhances 1alpha,25-dihydroxyvitamin D3 effects by increasing vitamin D receptor transcription.Pomalidomide in combination with dexamethasone results in synergistic anti-tumour responses in pre-clinical models of lenalidomide-resistant multiple myeloma.Differential targeting of androgen and glucocorticoid receptors induces ER stress and apoptosis in prostate cancer cells: a novel therapeutic modality.Exploring the molecular mechanisms of glucocorticoid receptor action from sensitivity to resistance.Glucocorticoid receptors: finding the middle ground.Selective Glucocorticoid Receptor Modulators (SGRMs) Delay Castrate-Resistant Prostate Cancer Growth.Nuclear bioavailability of the glucocorticoid receptor in a pediatric asthma cohort with variable corticosteroid responsiveness.Combination of a selective activator of the glucocorticoid receptor Compound A with a proteasome inhibitor as a novel strategy for chemotherapy of hematologic malignancies.Endothelial glucocorticoid receptor promoter methylation according to dexamethasone sensitivity.Plasmodium berghei NK65 in Combination with IFN-γ Induces Endothelial Glucocorticoid Resistance via Sustained Activation of p38 and JNK.Novel role for receptor dimerization in post-translational processing and turnover of the GRα
P2860
Q26782111-51DBE3E4-8898-462B-BAEE-17DE3F360A7FQ35378668-CE52E57A-DED5-4EF6-9785-3B58F78E4BBDQ35935794-CE054997-AEBA-4CB9-BA31-8A975D788890Q35974731-8151F07F-636D-4292-A495-4B215E8FDAD5Q36628635-217FEDFC-4910-4706-9BCC-71F1F6AD56A2Q38742875-F9678DBD-A942-4E84-A898-0C59EBEF61AEQ38827723-79D7ECC2-9C3D-4AD1-B30E-6B4B908E609EQ38844013-DC9191CC-8E8C-40B1-8A5C-46AEAB6A400EQ39223255-FF5B377A-E971-48B6-829C-CCA6A22B5966Q42061655-3EC90DA3-D658-4BEB-BA72-74955BF2157EQ42369143-56C32C72-914D-424B-8225-06ED53714BF6Q58700383-065E4742-9D2C-45DC-A547-F84F5D303C7A
P2860
Lysine 419 targets human glucocorticoid receptor for proteasomal degradation.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Lysine 419 targets human glucocorticoid receptor for proteasomal degradation.
@ast
Lysine 419 targets human glucocorticoid receptor for proteasomal degradation.
@en
Lysine 419 targets human glucocorticoid receptor for proteasomal degradation.
@nl
type
label
Lysine 419 targets human glucocorticoid receptor for proteasomal degradation.
@ast
Lysine 419 targets human glucocorticoid receptor for proteasomal degradation.
@en
Lysine 419 targets human glucocorticoid receptor for proteasomal degradation.
@nl
prefLabel
Lysine 419 targets human glucocorticoid receptor for proteasomal degradation.
@ast
Lysine 419 targets human glucocorticoid receptor for proteasomal degradation.
@en
Lysine 419 targets human glucocorticoid receptor for proteasomal degradation.
@nl
P2093
P2860
P1433
P1476
Lysine 419 targets human glucocorticoid receptor for proteasomal degradation
@en
P2093
Andrew D Wallace
Sindhu Chandramouleeswaran
P2860
P304
P356
10.1016/J.STEROIDS.2010.06.015
P577
2010-07-07T00:00:00Z